Used for quantifying ATP-citrate lyase (ACLY) enzyme activity in human biological samples such as cell lysates or tissue extracts. This ELISA kit enables researchers to measure changes in ACLY activity in metabolic studies, particularly in research related to lipid synthesis, glucose metabolism, and insulin signaling. It is widely applied in studies of metabolic disorders like obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD). Additionally, it supports cancer research since ACLY plays a role in tumor cell proliferation and is considered a potential therapeutic target in oncology. The kit provides a reliable and sensitive method for monitoring the effects of drugs or genetic manipulations on ACLY function in human-derived samples.